Gallery
Photos from events, contest for the best costume, videos from master classes.
 |  |
 |  |
 |  |
 |  |
 |  |
 |  |
In accordance with a new state law, the anticonvulsant and nerve pain medication gabapentin will soon be added to the list of drugs tracked through the state’s prescription drug management program (PDMP), the NC Controlled Substances Reporting System (NC CSRS). It is not classified as a controlled substance at the federal level in the United States (though some states have enacted regulations). However, emerging data and clinical observations show that gabapentin does carry a risk for misuse and dependence, particularly in individuals with a history of substance use disorders. 2025 Law and Responsible Person Review, Virtual Presentations Join the Board for presentations throughout 2025 to learn about the latest developments in pharmacy laws and rules. This bill amends Montana's drug scheduling law to add gabapentin to Schedule V controlled substances, which is a category of drugs with lower potential for abuse. Currently, Schedule V includes certain narcotic drugs with limited quantities of non-narcotic ingredients, stimulants, depressants, anticonvulsant substances, and antimigraine medications. Specifically, the bill inserts gabapentin Dear Licensee, The Bureau of Professional Licensing (BPL) within the Michigan Department of Licensing and Regulatory Affairs (LARA) would like to inform you that the Pharmacy – Controlled Substances Rules have been revised and the changes are effective immediately. One particular amendment of note is the descheduling of Gabapentin, meaning it is no longer classified as a controlled substance Gabapentin is not classified as a controlled substance on the federal level. However, there are growing concerns about the potential risks. Here’s what to know. Montana lawmakers are taking significant steps to address the growing concerns surrounding drug misuse with the introduction of House Bill 41. Proposed by Representative C. Schomer at the request of the Department of Justice, this bill aims to revise the list of specific dangerous drugs classified under Schedule V of the state's controlled substances. The primary focus of House Bill 41 is to 2. Is Gabapentin a controlled substance in North Carolina? • No, Gabapentin is not a controlled substance in North Carolina. 3. Do Gabapentin dispensations have to be reported to the Controlled Substance Reporting System? • Yes, beginning March 1, 2024, Gabapentin dispensations are required to be reported by dispensers. 4. Gabapentin is used to treat many conditions, including seizures and pain conditions. Gabapentin is not a controlled substance on a federal level but is controlled in some states, which limits the number of prescription refills and how it is reported. Gabapentin can be dangerous when used in combination with other substances, particularly opioids. Gabapentin, originally developed to treat epilepsy, has gained popularity as a medication for neuropathic pain and other conditions. However, its increasing use has raised concerns about potential misuse and addiction. As a result, various states have begun to classify gabapentin as a controlled substance. Understanding the legal status of gabapentin across different jurisdictions is crucial Gabapentin is a controlled substance in states like Michigan and Kentucky, while others have mandated reporting rules. Learn about its risk for abuse here. Gabapentin, initially developed for epilepsy, is now widely used for nerve pain and other off-label applications. Rising prescription rates have sparked discussions about whether it should be classified as a controlled substance due to concerns over misuse and dependency. Gabapentin is a prescription medication approved by the FDA for the treatment of neuropathic pain (postherpetic neuralgia) and seizure disorders. Why is gabapentin controlled in some states? Gabapentin is structurally and pharmacologically related to pregabalin (Lyrica, Lyrica CR), which is a Schedule V drug and controlled federally in all states. As of June 2024, gabapentin remains a non-controlled substance under the U.S. federal government. With mounting evidence of misuse and abuse of gabapentin use, certain states have implemented regulations or policies to limit or monitor the use of the drug, especially given its potential to enhance the effects of opioids. Will Gabapentin prescription histories be available in the Controlled Substance Reporting System? • Yes, Gabapentin prescription histories will be available to practitioners with a Controlled Substances Reporting System (CSRS) registration. Adds Gabapentin to the list of substances to be reported into the CSRS, by dispensers, effective March 1, 2024; this law requires veterinarians to report prescriptions of Gabapentin effective March 1, 2025. To date, the following states have also taken steps to classify gabapentin as a controlled substance: Alabama Michigan North Dakota Utah Virginia Although gabapentin is not a controlled substance in the following states, there is stricter prescription monitoring for potential misuse. As of April 2025, these states include: Connecticut Indiana NC Controlled Substances Reporting System (CSRS) Reporting Gabapentin Dispensations FAQ for Veterinarian Medicine Prescribers This Frequently Asked Questions document has been created to address the implementation of required Gabapentin reporting in the NC CSRS in the Session Law 2023-65 Part XI Section 11.1 G.S. 90-113.73(b) 1. 2. Is Gabapentin a controlled substance in North Carolina? • No, Gabapentin is not a controlled substance in North Carolina. 3. Do Gabapentin dispensations have to be reported to the Controlled Substance Reporting System? • Yes, beginning March 1, 2024, Gabapentin dispensations are required to be reported by dispensers. 4. We would like to show you a description here but the site won’t allow us.
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
| |
| |
| |
| |
| |
| |